Largest Clinical Trials companies in France by Market Capitalization
France
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 496.20 M |
Jan. 14, 2025 | USD 16.86 | 0.98% |
|
France |
|
| 2 |
USD 417.58 M |
Jan. 14, 2025 | USD 6.25 | -0.54% |
|
France |
|
| 3 |
USD 218.60 M |
Jan. 14, 2025 | USD 2.29 | 4.37% |
|
France |
|
| 4 |
USD 178.54 M |
Jan. 14, 2025 | USD 1.74 | -2.29% |
|
France |
|
| 5 |
USD 174.83 M |
Jan. 14, 2025 | USD 3.40 | -0.30% |
|
France |
|
| 6 |
USD 152.09 M |
Jan. 14, 2025 | USD 6.91 | 0.46% |
|
France |
|
| 7 |
USD 119.04 M |
Jan. 14, 2025 | USD 8.53 | 3.61% |
|
France |
|
| 8 |
USD 100.36 M |
Jan. 14, 2025 | USD 2.22 | -0.32% |
|
France |
|
| 9 |
USD 95.20 M |
Jan. 14, 2025 | USD 4.64 | -14.23% |
|
France |
|
| 10 |
USD 95.09 M |
Jan. 14, 2025 | USD 6.08 | 1.81% |
|
France |
|
| 11 |
USD 23.79 M |
Jan. 14, 2025 | USD 1.50 | -9.33% |
|
France |
Frequently Asked Questions
-
Which Clinical Trials company in France has the highest Market Capitalization ?
The Clinical Trials company in France with the highest Market Capitalization is MedinCell S.A. (Paris Stock Exchange: MEDCL.PA) at USD 496.20 M.
-
Which Clinical Trials company in France has the lowest Market Capitalization ?
The Clinical Trials company in France with the lowest Market Capitalization is Valbiotis SA (Paris Stock Exchange: ALVAL.PA) at USD 23.79 M.
-
What are the top 10 Clinical Trials companies in France by Market Capitalization ?
The top 10 Clinical Trials companies in France by Market Capitalization are MedinCell S.A., ABIVAX Société Anonyme, Inventiva S.A., Cellectis S.A., Genfit S.A., OSE Immunotherapeutics SA, MaaT Pharma SA, Crossject Société Anonyme, DBV Technologies S.A. and Adocia SA.
-
What are the bottom 10 Clinical Trials companies in France by Market Capitalization ?
The bottom 10 Clinical Trials companies in France by Market Capitalization are Valbiotis SA, Adocia SA, DBV Technologies S.A., Crossject Société Anonyme, MaaT Pharma SA, OSE Immunotherapeutics SA, Genfit S.A., Cellectis S.A., Inventiva S.A. and ABIVAX Société Anonyme.